BHCUX Holdings Information

BHCUX is a mutual fund with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 13.65%, Mettler-Toledo International at 5.59%, Johnson & Johnson at 5.56%, argenx SE at 4.22%, and Thermo Fisher Scientific at 3.91%.

Total Holdings

Top 10 Percentage

50.93%

Asset Class

Equity

Fund Category

Health

Assets

104.31M

Forward PE Ratio

28.32

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	13.65%	13,000
2	MTD	Mettler-Toledo International Inc.	5.59%	5,000
3	JNJ	Johnson & Johnson	5.56%	25,000
4	ARGX	argenx SE	4.22%	5,200
5	TMO	Thermo Fisher Scientific Inc.	3.91%	8,900
6	ROIV	Roivant Sciences Ltd.	3.87%	125,000
7	TEVA	Teva Pharmaceutical Industries Limited	3.86%	130,000
8	UNH	UnitedHealth Group Incorporated	3.64%	10,000
9	WELL	Welltower Inc.	3.38%	17,000
10	RDNT	RadNet, Inc.	3.24%	60,000
11	BLLN	BillionToOne, Inc.	2.84%	27,000
12	EW	Edwards Lifesciences Corporation	2.64%	33,300
13	VRTX	Vertex Pharmaceuticals Incorporated	2.61%	6,000
14	LON: AZN	AstraZeneca PLC	2.49%	15,000
15	MRK	Merck & Co., Inc.	2.48%	22,000
16	GH	Guardant Health, Inc.	2.17%	16,500
17	MDGL	Madrigal Pharmaceuticals, Inc.	2.12%	4,500
18	RVMD	Revolution Medicines, Inc.	2.05%	12,500
19	ELAN	Elanco Animal Health Incorporated	2.05%	95,000
20	KYMR	Kymera Therapeutics, Inc.	2.01%	20,000
21	n/a	Usd	2.00%	2,279,568
22	GILD	Gilead Sciences, Inc.	1.99%	18,000
23	NTRA	Natera, Inc.	1.93%	8,100
24	ISRG	Intuitive Surgical, Inc.	1.74%	5,000
25	PTGX	Protagonist Therapeutics, Inc.	1.72%	16,000

Showing 25 of 45 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026